Sign In
Buy UTHR
$549.47
+9.42 (+1.74%)
At Close: Jun 03, 2026
Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Friday, 04'th Jul 2025
United Therapeutics (UTHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
09:56am, Wednesday, 02'nd Jul 2025
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of 3D Systems Corporation(DDD) Shareholders
09:36am, Monday, 30'th Jun 2025
NEW YORK - June 30, 2025 (NEWMEDIAWIRE) - Levi & Korsinsky, LLP notifies investors in 3D Systems Corporation ("3D Systems Corporation" or the "Company") (NYSE: DDD) of a class action securities lawsui
Why United Therapeutics (UTHR) is a Top Value Stock for the Long-Term
10:45am, Thursday, 26'th Jun 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
EDEN PRAIRIE, Minn. & MURRAY, Utah--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, and Intermountain Health, one of the nation's top health systems and
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced the conclusion of enrollment of the phase 3
United Therapeutics (UTHR) Soars 3.5%: Is Further Upside Left in the Stock?
03:36am, Friday, 13'th Jun 2025
United Therapeutics (UTHR) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price in
United Therapeutics: Tanking On Rival's PAH Data - I'd Consider Buying Stock
01:36pm, Wednesday, 11'th Jun 2025
United Therapeutics Corporation stock was down substantially yesterday as rival Insmed's PAH data blew the market away. Insmed's treprostinil based product seemingly edged United's Tyvaso on key measu
Why Is United Therapeutics (UTHR) Up 9% Since Last Earnings Report?
12:37pm, Friday, 30'th May 2025
United Therapeutics (UTHR) reported earnings 30 days ago. What's next for the stock?
The Top 3 Stock Picks at the World's Greatest Hedge Fund
07:16am, Friday, 02'nd May 2025
A reclusive firm is often considered the world's most successful hedge fund. That company is Renaissance Technologies.
UTHR Q1 Earnings & Revenues Beat Estimates on Higher Tyvaso Sales
09:00am, Thursday, 01'st May 2025
United Therapeutics reports better-than-expected first-quarter 2025 results, beating both earnings and revenue estimates, driven mainly by strong Tyvaso sales.
United Therapeutics Corporation (UTHR) Q1 2025 Earnings Call Transcript
01:09pm, Wednesday, 30'th Apr 2025
United Therapeutics Corporation (NASDAQ:UTHR ) Q1 2025 Earnings Conference Call April 30, 2025 9:00 AM ET Company Participants Dewey Steadman - Head of Investor Relations Martine Rothblatt - Chairpers
United Therapeutics (UTHR) Reports Q1 Earnings: What Key Metrics Have to Say
10:35am, Wednesday, 30'th Apr 2025
While the top- and bottom-line numbers for United Therapeutics (UTHR) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metri
United Therapeutics (UTHR) Q1 Earnings and Revenues Top Estimates
08:35am, Wednesday, 30'th Apr 2025
United Therapeutics (UTHR) came out with quarterly earnings of $6.63 per share, beating the Zacks Consensus Estimate of $6.29 per share. This compares to earnings of $6.17 per share a year ago.
United Therapeutics Corporation Reports First Quarter 2025 Financial Results
06:30am, Wednesday, 30'th Apr 2025
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter
